| abstract |
An object of the present invention is to provide a pharmaceutical product containing a compound having an excellent therapeutic effect on inflammatory bowel disease. A therapeutic agent for inflammatory bowel disease, which contains a compound represented by formula (I) or a pharmacologically acceptable salt thereof as an active ingredient, wherein in general formula (I), R 1 represents a hydroxy C 1 -C 6 alkyl group, C 2 -C 7 alkanoyl, C 2 -C 7 alkanoyl C 1 -C 6 alkyl, (C 1 -C 6 alkoxy) carbonyl, (C 1 -C 6 alkoxy) carbonyl C 1 -C 6 alkyl group, carboxyl group or carboxyl group C 1 -C 6 alkyl group. [Formula 1] |